Drugs / BN82451B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02231580 | Sep 2014 → Mar 2016 | Huntington disease | Ipsen | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BN82451B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02231580 ↗ |
| Route | Oral | “administered orally” NCT02231580 ↗ |